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December 20111870 Letters to the Editorrate of secondary procedures in the long-term period in patients
treated with fenestrated stent grafts is not negligible,3 and the chim-
ney technique shows satisfying results in series with a small number of
patients with a short-term follow-up.4
The Endurant stent graft is a new-generation device and we
are expecting better long-term results in terms of migration, mod-
ule disconnection, and fatigue of the materials than those offered
by the first- and second-generation devices.5 So, we confirm the
cautious application in selected patients of endovascular aneurysm
repair outside the Endurant-specific IFU.2
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Carotid artery stenting may be contraindicated in
female patients with symptomatic carotid artery
stenosis
Carotid artery stenting (CAS) has reported inferior outcomes
compared with carotid endarterectomy (CEA) for the manage-
ment of symptomatic carotid artery stenosis.1 The 2011 guidelines
by the American Heart Association/American Stroke Association
(AHA/ASA) and several other associations recommended CAS as
an “alternative to CEA for symptomatic patients” (class I; level of
evidence B).2 The AHA/ASA Guidelines used the Carotid Revas-
cularization Endarterectomy versus Stenting Trial (CREST) to
support this recommendation.3
CREST recently reported a subgroup analysis on the influ-
ence of sex on outcomes after CAS compared with CEA.4
Although symptomatic men showed similar periprocedural
stroke rates whether undergoing CAS or CEA (3.3% vs 2.4%,
respectively; hazard ratio [HR], 1.39; 95% confidence interval
[CI], 0.78-2.48; P  .26), women assigned to CAS had 2.5-
fold higher periprocedural stroke rates compared with those
undergoing CEA (5.5% vs 2.2%, respectively; HR, 2.63; 95%
CI, 1.23-5.65; P  .013). Similar results were reported for
periprocedural death rates. As the authors commented,
4women might be at higher risk of periprocedural stroke and
eath because of technical difficulties related to the fact that
hey have smaller internal carotid arteries than men; women,
n average, have 40% smaller internal carotid arteries than
en.”4
Another recent report compared the outcomes of CAS vs CEA
n women vs men using the Nationwide Inpatient Sample (n 
4,658 procedures) during 2004 and 2005.5 Although females
ad similar rates of perioperative stroke with males undergoing
EA (1.0% vs 1.0%, respectively; P  .9) or CAS (2.7% vs 2.0%,
espectively; P  .2), symptomatic women had higher periopera-
ive stroke rates compared with either asymptomatic females (3.8%
s 0.9%, respectively; P  .001) or symptomatic men (3.8% vs
.3%, respectively; P  .03).5 The conclusion reached was that
CEA may be the preferred treatment in female patients who
arrant intervention for cerebrovascular disease, unless compelling
easons exist to perform CAS.”5
Maneuvering CAS guidewires and catheters in the smaller
emale carotid arteries with “unstable” plaques may produce more
icroemboli than inmales; these microemboli may account for the
ncreased periprocedural stroke rates in symptomatic female pa-
ients undergoing CAS.4,5
The inferior results of CAS compared with CEA for symp-
omatic female patients,4,5 therefore, indicate that CAS is not an
cceptable “alternative” to CEA in this group of patients.
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Reply
Ever since the Asymptomatic Carotid Atherosclerosis Study
(ACAS) Study1 reported that an increased perioperative stroke rate
following carotid endarterectomy (CEA) in female patients greatly
diminished or possibly eliminated the potential benefit of prophy-
lactic CEA, there has been controversy and concern regarding the
outcome of cerebrovascular interventions in female patients. In a
subsequent large single-institutional study addressing this specific
issue, men and women were found to have equal rates of periop-
erative myocardial infarction (MI), mortality and stroke following
CEA.2 However, the cohort of patients with the highest perioper-
ative stroke rate was symptomatic female patients, with a stroke
incidence of 3.0% following CEA.2 Clearly, symptomatic women
may represent a cohort of patients with increased risk.
The majority of the studies on this topic have compared the
outcome of female patients to male patients. While these are worth-
while comparisons, one needs to keep in mind that it remains unclear
whether the natural history and outcome of patients with severe
cerebrovascular disease differs based on sex. It is certainly feasible that
women with symptomatic severe carotid artery stenosis may have a
worse outcome than corresponding male patients when treated with
“bestmedical” or noninterventional therapies. It is possible, of course,
that symptomatic female patients would be at a higher risk of future
stroke compared with men if no intervention were performed, and
would still benefit from cerebrovascular intervention as opposed to
medical management. Hence, the truly important comparison is not
female outcome vsmale outcome, but rather female outcome based on
the treatment performed: what is the best treatment for symptomatic
female patients with severe carotid artery disease? Should symptom-
atic female patients be treated with CEA, or with carotid artery
angioplasty and stenting (CAS)?
With these issues in mind, Drs. Paraskevas, Mikhailidis, and
Veith have authored a provocative letter stating that “CAS is not an
acceptable ‘alternative’ to CEA in this group of patients.” Their
concern stems from the recent AHA/ASA Guidelines,3 which do
clearly recommendCAS as an “alternative to CEA for symptomatic
patients.” Dr. Paraskevas and his coauthors cite subsequent litera-
ture from the Carotid Revascularization Endarterectomy Versus
Stenting (CREST) trial,4 as well as a recently published review of
the Nationwide Inpatient Sample (NIS)5 to support their conclu-
sion regarding the inferior outcome of CAS in symptomatic
women. As seen in the Table below, the CREST trial reports a
periprocedural stroke rate in symptomatic women of 7.5% for CAS
vs 2.7% with CEA (P  .03).4 The long-term rate of stroke in
symptomatic women from the CREST report is 10.4% with CAS,
vs 6.9% with CEA (P .18).4 Finally, the review of the NIS reports
a periprocedural stroke rate in symptomatic women of 6.2% with
CAS vs 3.4% for CEA (P  .1).5
In summary, data from both a large randomized prospective
trial and an extensive national database clearly suggest a poorer
outcome following CAS in symptomatic female patients. Based on
the existing literature, as delineated above, I share the authors’
concern regarding the appropriateness of CAS in symptomatic
female patients. Of course, an individual treatment decision with
regard to a particular patient must take into account many specific
details, including both anatomic factors and patient comorbidities.
However, the existing literature appears to show that CEA may be
the preferred treatment in female patients who warrant interven-
tion for symptomatic cerebrovascular disease, unless compelling
reasons exist to perform CAS.
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egarding “Repairing immediate proximal endoleaks
uring abdominal aortic aneurysm repair”
Rajani et al1 retrospectively reviewed data of 72 infrarenal
bdominal aortic aneurysm (AAA) patients with an intraoperatively
iagnosed type Ia endoleak requiring a Palmaz stent or covered
tent graft cuff placement. They concluded that both methods
ppear to be durable long-term options to facilitate endovascular
xclusion of AAA, with the results that no recurrent type Ia
ndoleak developed in the Palmaz stent group and three reinter-
entions were required in the cuff group. Given the lack of data
able. Representative periprocedural stroke rates
eported in the literature in symptomatic women
ndergoing carotid endarterectomy and carotid artery
ngioplasty and stenting
troke rate in
ymptomatic women CEA CAS P value
REST, perioperative4 2.7% 7.5% 0.03
REST, long-term4 6.9% 10.4% 0.2
IS5 3.4% 6.2% 0.1
REST, Carotid Revascularization Endarterectomy Versus Stenting; NIS,
ationwide Inpatient Sample.ssessing long-term outcomes of cuff and Palmaz (Cordis, Miami
akes, Fla) stent placement after immediate type Ia endoleak, we
